Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients

Blood

Volumn 91, Issue 2, 1998, Pages 549-554

  Polgár, János ^b   Eichler, Petra ^b   Greinacher, Andreas ^b   Clemetson, Kenneth J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPYLTHIO BETA,GAMMA DIFLUOROMETHYLENE; ADENOSINE DIPHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; APYRASE; AR C 66096; ARACHIDONIC ACID; DALTROBAN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LAMIFIBAN; LY 288570; MONOCLONAL ANTIBODY; N ACETYLGALACTOSAMINE 4 SULFATASE; THROMBIN; THROMBIN INHIBITOR; THROMBOXANE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG ANTAGONISM; HEPARINIZATION; HUMAN; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0031963059     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.2.549     Document Type: Article

References (37)

1. Greinacher A: Antigen generation in heparin-associated thrombocytopenia: The nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 21:106, 1995
2. Chong BH: Heparin-induced thrombocytopenia. Br J Haematol 89:431, 1995
3. Weismann RE, Tobin RW: Arterial embolism occurring during systemic heparin therapy. Arch Surg 76:219, 1958
4. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D: Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68:95, 1992
5. Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C: Heparin-associated thrombocytopenia: Isolation and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 71:247, 1994
6. Kelton JG, Smith JW, Warkentin TE, Hayward CPM, Denomme GA, Horsewood P: Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 83:3232, 1994
7. Visentin GP, Ford SE, Scott JP, Aster RH: Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93:81, 1994
8. Kelton JG, Sheridan D, Santos A, Smith J, Steves K, Smith C, Brown C, Murphy WG: Heparin-induced thrombocytopenia: Laboratory studies. Blood 72:925, 1988
9. Chong BH, Fawaz I, Chesterman CN, Berndt MC: Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73:235, 1989
10. Adelman B, Sobel M, Fijimura T, Ruggeri ZM, Zimmerman TS: Heparin-associated thrombocytopenia: Observations on the mechanism of platelet aggregation. J Lab Clin Med 113:204, 1989
11. Anderson GP: Insights into heparin-induced thrombocytopenia. Br J Haematol 80:504, 1992
12. Anderson CL, Chacko GW, Osborne JM, Brandt JT: The Fc receptor for immunoglobulin G (FcγRII) on human platelets. Semin Thromb Hemost 21:1, 1995
13. Brandt JT, Osborne JM, Chacko G, Anderson CL: The role of FcγRIIA phenotype in heparin-induced thrombocytopenia. Thromb Haemost 74:1564, 1995
14. Burgess JK, Lindeman R, Chesterman CN, Chong BH: Single amino acid mutation of Fc γ receptor is associated with the development of heparin-induced thrombocytopenia. Br J Haematol 91:761, 1995
15. Arepally G, McKenzie SE, Jiang XM, Poncz M, Cines DB: FcγRIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/ platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood 89:370, 1997
16. Aster RH: Heparin-induced thrombocytopenia: Understanding improves but questions remain. J Lab Clin Med 127:418, 1996
17. Handin RI, Cohen HJ: Purification and binding properties of human platelet factor four. J Biol Chem 251:4273, 1976
18. Greinacher A, Alban S, Dummel V, Franz G, Mueller-Eckhardt C: Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia. Thromb Haemostas 74: 886, 1995
19. Holmsen H, Dangelmaier CA: Measurement of secretion of adenine nucleotides. Methods Enzymol 169:195, 1989
20. Greinacher A, Liebenhoff U, Kiefel V, Presek P, Mueller-Eckhardt C: Heparin-associated thrombocytopenia: The effects of various intravenous IgG preparations on antibody mediated platelet activation - A possible new indication for high dose i.v. IgG. Thromb Haemost 71:641, 1994
21. Sheridan D, Carter C, Kelton JG: A diagnostic test for heparin-induced thrombocytopenia. Blood 67:27, 1986
22. Stewart MW, Etches WS, Boshkov LK, Gordon PA: Heparin-induced thrombocytopenia: an improved method of detection based on lumi-aggregometry. Br J Haematol 91:173, 1995
23. Plow EF, D'Souza SE, Ginsberg MH: Consequences of the interaction of platelet membrane glycoprotein GPIIb-IIIa (alpha IIb beta 3) and its ligands. J Lab Clin Med 120:198, 1992
24. Hovig T: Release of a platelet aggregatory substance adenosine diphosphate from rabbit blood platelets induced by saline extracts of tendons. Thrombosis et Diathesis Haemorrhagica 9:264, 1963
25. Mills DCB: ADP receptors on platelets. Thromb Haemost 76:835, 1996
26. Leon C, Hechler B, Vial C, Leray C, Cazenave JP, Cachet C: The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 403:26, 1997
27. Humphries RG, Tomlinson W, Ingall AH, Cage PA, Leff P: FPL66096: A novel, highly potent and selective antagonist at human platelet P 2T-purinoceptors. Br J Pharmacol 113:1057, 1994
28. Humphries RG, Robertson MJ, Leff P: A novel series of P2T-purinoceptor antagonists: Definition of the role of ADP in arterial thrombosis. Trends Pharmacol Sci 16:179, 1995
29. Cattaneo M, Lombardi R, Zighetti ML, Gachet C, Ohlmann P, Cazenave J-P, Mannucci PM: Deficiency of [33 P]2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A 2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A 2 production. Thromb Haemost 77:986, 1997
30. Home MK III, Alkins BR: Platelet binding-of IgG from patients with heparin-induced thrombocytopenia. J Lab Clin Med 127:435,1996
31. Suh JS, Aster RH, Visentin GP: Affinity-purified antibodies from patients with heparin-induced thrombocytopenia (HITP) recognize multiple sites on heparin:PF4 complexes and react with platelets and endothelial cells. Blood 86:444a, 1995 (abstr)
32. Barber AJ, Kaser-Glanzmann R, Jakabova M, Luscher EF: Characterization of chondroitin 4-sulfate proteoglycan carrier for heparin neutralizing activity (platelet factor 4) released from human blood platelets. Biochim Biophys Acta 286:312, 1972
33. Huang SS, Huang JS, Deuel TF: Proteoglycan carrier of human platelet factor 4. Isolation and characterisation. J Biol Chem 257:11546, 1982
34. Kolset SO, Mann DM, Uhlin-Hansen L, Winberg J-O, Ruoslahti E: Serglycin-binding proteins in activated macrophages and platelets. J Leukoc Biol 59:545, 1996
35. Levine SP, Knieriem LK, Rager MA: Platelet factor 4 and the platelet secreted proteoglycan: Immunologic characterization by crossed immunoelectrophoresis. Blood 75:902, 1990
36. Mason IJ: The ins and outs of fibroblast growth factors. Cell 78:547, 1994
37. Greinacher A, Amiral J, Dummel V, Vissac AM, Kiefel V, Mueller-Eckhardt C: Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 34:381, 1994